Genome-wide Single Cell Haplotyping as a Generic Method for Preimplantation Genetic Diagnosis
NCT01336400 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2011-04-15
Summary
The investigators previously developed approaches to SNP-, CNV- and haplo-type single human cells (Vanneste et al. 2009, Nature Medicine). These methods open the possibility to be developed into a novel generic diagnostic technique which broadens the spectrum of disease-alleles that can be selected against during preimplantation genetic diagnosis (PGD) and which enables to help those couples that cannot be supported by PGD yet. PGD is the genetic analysis of a single blastomere from an in vitro fertilized (IVF) embryo and it is offered to couples to avoid the transmission of heritable genetic disorders to their offspring. PGD analyses are performed for (1) autosomal dominant or recessive monogenic diseases, (2) X-linked disorders and (3) chromosomal aberrations that may result in aneuploid conceptions. This novel method is likely to outperform and hence, replace current techniques for preimplantation genetic diagnosis. In this project the investigators will bring the technology from a proof-of-principle to the clinical application. To this end the investigators will make computational improvements for accurate single blastomere SNP-, CNV- and haplo-typing and perform a large validation study. For the validation studythe investigators will analyse the genomes of the blastomeres derived from 60 spare embryos of different origin: (1) Embryos diagnosed as genetically abnormal using current PCR- and FISH-protocols. (2) Embryos diagnosed as normal for the investigated region using current PCR- and FISH-protocols, but not of sufficient quality to be transferred or frozen. (3) Embryos of the sex that is selected against following PGD based sex-selection, or embryos of the sex that is selected for but of insufficient quality to be transferred or frozen. (4) Embryos that were not biopsied in a PGD cycle since they suffer a slight growth delay. This validation study will allow us to evaluate (1) the clinical validity (false positive and negative rate) and (2) clinical applicability (in terms of ease of use, success rate, etc.). In addition, it will bring us essential further fundamental insights in the origins and mechanisms of chromosomal instability operating during early embryogenesis and its consequences for clinical applications of PGD. Finally, following the validation study, this project will clinically implement the technique to treat 10 families.
Conditions
- Preimplantation Genetic Diagnosis
Interventions
- OTHER
-
single cell haplotyping
We aim to collect single blastomeres from spare IVF embryos of 30 couples to optimize and test methods for single cell haplotyping. We aim to collect 20 and 10 couples coming to the fertility centre for FISH- or PCR-based PGD respectively. In both groups, at least 5 different indications for PGD will be collected. Per couple, we will perform 10 SNP-arrays: 2 for the couple donating the embryo, 4 for family members (often parents of the couple) and 4 for blastomeres since we aim to pick 2 cells from 2 embryos per couple. For five couples, 2 blastomeres of all available embryos will be aspirated to validate and optimize the phasing methods. Finally, for some embryos, all blastomeres will be picked to be able to prove the reproducibility of single cell haplotyping.
Sponsors & Collaborators
-
KU Leuven
collaborator OTHER -
Universitair Ziekenhuis Brussel
collaborator OTHER -
Vrije Universiteit Brussel
collaborator OTHER -
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Joris R Vermeesch, Professor · Universitaire Ziekenhuizen KU Leuven
-
Thierry Voet, Professor · KU Leuven
-
Thomas D'Hooghe, Professor · Universitaire Ziekenhuizen KU Leuven
-
Yves Moreau, Professor · KU Leuven
-
Karen Sermon, Professor · Vrije Universiteit Brussel
-
De Rycke Martine, Professor · Universitair Ziekenhuis Brussel
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- Belgium
Study Locations
More Related Trials
-
Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening
NCT03173885 ·Status: TERMINATED ·Phase: NA
-
Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH
NCT01546350 ·Status: SUSPENDED ·Phase: PHASE2
-
Predictive Value of Embryonic Testing
NCT03604107 ·Status: COMPLETED
-
Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure
NCT03900780 ·Status: RECRUITING ·Phase: NA
-
Genetic Screening and Assisted Oocyte Activation in Couples with Diminished/aberrant Embryonic Development.
NCT03354013 ·Status: COMPLETED ·Phase: NA
-
Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)
NCT01023048 ·Status: COMPLETED ·Phase: NA
-
PGS Using Microarray in IVF Patients With Repeated Implantation Failure
NCT02265614 ·Status: UNKNOWN ·Phase: NA
-
Follow-up With Preimplantation Genetic Testing Patients
NCT04477863 ·Status: RECRUITING
-
Cell Free Preimplantation Genetic Testing
NCT04628507 ·Status: NOT_YET_RECRUITING
-
Study of the Efficacy of 24 Chromosome Preimplantation Genetic Diagnosis (PGD)
NCT01219283 ·Status: COMPLETED
-
Preimplantation Genetic Screening (PGS) in Advanced Female Age and Male Severe Factor
NCT01571076 ·Status: COMPLETED ·Phase: NA
-
Implantation Failure and PGD
NCT00547781 ·Status: COMPLETED ·Phase: PHASE4
-
Embryos With Preimplantation Genetic Testing for Aneuploidies (PGT-A) Inconclusive Result: Clinical Implications
NCT04734769 ·Status: UNKNOWN
-
Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age
NCT00646893 ·Status: SUSPENDED ·Phase: PHASE4
-
Single Embryo TrAnsfeR of Euploid Embryo
NCT02268786 ·Status: COMPLETED ·Phase: NA
-
Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis
NCT07076719 ·Status: COMPLETED
-
Utilizing Free DNA in Embryo Culture for PGT
NCT02884063 ·Status: COMPLETED
-
Next Generation Sequencing Screening for Embryonic Ploidy Status
NCT02032264 ·Status: COMPLETED ·Phase: NA
-
Gene Expression in Cumulus Cells to Predict Pregnancy
NCT01732900 ·Status: COMPLETED ·Phase: NA
-
Efficiency of Comprehensive Chromosomal Testing of Trophectoderm Biopsies of Blastocysts in In Vitro Fertilization
NCT04758819 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Preimplantation Genetic Testing for Aneuploidies Using Cell-free DNA in Spent Culture Media
NCT04711239 ·Status: WITHDRAWN
-
Pre-implantation Genetic Testing for Monogenic Disease: Single Center Experience
NCT05936749 ·Status: COMPLETED
-
Isolation of Cell Free Fetal DNA From Spent Culture Medium and Its Potential Role for Preimplantation Genetic Diagnosis (PGD).
NCT06084377 ·Status: COMPLETED
-
Establishment of Comprehensive Genetic Analysis From a Single Cell
NCT00173732 ·Status: UNKNOWN
-
Preimplantation Genetic Screening in Women of Advanced Maternal Age
NCT00795795 ·Status: COMPLETED ·Phase: NA